Description

Pyrazolo[1,5-A]Pyrazine-2-Carboxylic Acid, 4,5-Dihydro-6-(1-Methyl-1H-Pyrazol-4-Yl)-4-Oxo-, Ethyl Ester is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active pharmaceutical ingredients (APIs). This compound is critical for research and development in medicinal chemistry, offering a sophisticated heterocyclic scaffold for targeted drug discovery. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing novel therapeutic agents.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Fine Chemical Synthesis: Used in multi-step organic synthesis to construct complex molecular architectures with specific biological activity.
• Contract Research & Manufacturing (CRAM): Essential for organizations providing custom synthesis and process development services for the pharmaceutical industry.
• Academic Research: Employed in university and institutional labs for studying heterocyclic chemistry and developing new synthetic methodologies.

Basic Information

Product Name	Pyrazolo[1,5-A]Pyrazine-2-Carboxylic Acid, 4,5-Dihydro-6-(1-Methyl-1H-Pyrazol-4-Yl)-4-Oxo-, Ethyl Ester
CAS No.	1940180-25-5
Molecular Formula	C14H15N5O3
Molecular Weight	301.30 g/mol
Synonyms	Ethyl 4,5-dihydro-6-(1-methyl-1H-pyrazol-4-yl)-4-oxopyrazolo[1,5-a]pyrazine-2-carboxylate; 1940180-25-5; Pyrazolo[1,5-a]pyrazine-2-carboxylic acid, 4,5-dihydro-6-(1-methyl-1H-pyrazol-4-yl)-4-oxo-, ethyl ester; UNII-3V7G7B0V4U; 3V7G7B0V4U; SCHEMBL23320577; AKOS040759626; Ethyl 6-(1-methylpyrazol-4-yl)-4-oxo-4,5-dihydropyrazolo[1,5-a]pyrazine-2-carboxylate
EINECS	Contact for details

Quality Control

Our Pyrazolo[1,5-A]Pyrazine-2-Carboxylic Acid, 4,5-Dihydro-6-(1-Methyl-1H-Pyrazol-4-Yl)-4-Oxo-, Ethyl Ester is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all critical specifications. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your most demanding R&D and scale-up projects.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storage under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Residual Solvents (GC)	Complies with ICH Q3C

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.